India · Delayed Price · Currency is INR Eiko LifeSciences Statistics
Total Valuation
BOM:540204 has a market cap or net worth of INR 757.44 million. The enterprise value is 692.96 million.
| Market Cap | 757.44M |
| Enterprise Value | 692.96M |
Important Dates
The last earnings date was Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:540204 has 14.54 million shares outstanding. The number of shares has increased by 7.22% in one year.
| Current Share Class | 14.54M |
| Shares Outstanding | 14.54M |
| Shares Change (YoY) | +7.22% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 35.55% |
| Owned by Institutions (%) | 4.07% |
| Float | 5.31M |
Valuation Ratios
The trailing PE ratio is 16.74.
| PE Ratio | 16.74 |
| Forward PE | n/a |
| PS Ratio | 1.66 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.34 |
| EV / Sales | 1.52 |
| EV / EBITDA | 10.49 |
| EV / EBIT | 12.37 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | n/a |
| Interest Coverage | 19.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.84% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.16% |
| Revenue Per Employee | 65.20M |
| Profits Per Employee | 6.06M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:540204 has paid 16.65 million in taxes.
| Income Tax | 16.65M |
| Effective Tax Rate | 24.71% |
Stock Price Statistics
The stock price has increased by +5.22% in the last 52 weeks. The beta is -0.06, so BOM:540204's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | +5.22% |
| 50-Day Moving Average | 52.38 |
| 200-Day Moving Average | 52.73 |
| Relative Strength Index (RSI) | 50.38 |
| Average Volume (20 Days) | 7,621 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540204 had revenue of INR 456.37 million and earned 42.41 million in profits. Earnings per share was 3.11.
| Revenue | 456.37M |
| Gross Profit | 101.45M |
| Operating Income | 54.51M |
| Pretax Income | 67.36M |
| Net Income | 42.41M |
| EBITDA | 64.54M |
| EBIT | 54.51M |
| Earnings Per Share (EPS) | 3.11 |
Balance Sheet
The company has 80.87 million in cash and 10.09 million in debt, with a net cash position of 70.78 million or 4.87 per share.
| Cash & Cash Equivalents | 80.87M |
| Total Debt | 10.09M |
| Net Cash | 70.78M |
| Net Cash Per Share | 4.87 |
| Equity (Book Value) | 594.08M |
| Book Value Per Share | 42.62 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 22.23%, with operating and profit margins of 11.94% and 9.29%.
| Gross Margin | 22.23% |
| Operating Margin | 11.94% |
| Pretax Margin | 14.76% |
| Profit Margin | 9.29% |
| EBITDA Margin | 14.14% |
| EBIT Margin | 11.94% |
| FCF Margin | n/a |
Dividends & Yields
BOM:540204 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.22% |
| Shareholder Yield | -7.22% |
| Earnings Yield | 5.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |